Vue transversale de la maladie
Migraine
Un même point d’entrée pour les études cliniques, les découvertes scientifiques, les publications et les pistes exploratoires présentes dans Biomedical Watch.
Périmètre
Filtrer toute la vue
Chaque choix s’applique immédiatement aux quatre sections. Le filtre « type de SEP » n’apparaît que lorsque la sclérose en plaques est sélectionnée.
1236 résultats correspondants
· 45 visibles sur cette page
dans le périmètre Migraine
Niveau clinique
Études et traitements 570
Interventions, programmes et essais cliniques rattachés au périmètre sélectionné.
| Molécule / élément | Maladie / population | Objectif | Phase / stade | Statut / preuve | Mécanisme / résumé | Source | Détail |
|---|---|---|---|---|---|---|---|
| Caffeine (200 mg) NCT07022496 · Assessment of Oral Caffeine Intake in Changing the Severity of Acute Migraine At… | Migraine | À vérifier | Phase 4 | RECRUITING | Caffeine extracted from green tea to abort acute attack of Migraine À vérifier | ClinicalTrials.gov 2026-08-13 14:17:14 | Détail |
| HELP-VM — Healthy Living Partnerships for Veterans With Migraine NCT04373330 · NCT04373330 | Migraine | Traitement symptomatique | Non applicable | WITHDRAWN | This pilot study, modeled upon the successful and empirically validated HE… À vérifier | ClinicalTrials.gov 2026-08-13 14:17:14 | Détail |
| Partial Rebreathing Device NCT05546385 · PAREMA1 — PArtial REbreathing for Migraine With Aura 1 | Migraine | À vérifier | Non applicable | TERMINATED | A prospective, multi-centre, randomized, double-blind, sham-controlled, pa… À vérifier | ClinicalTrials.gov 2026-08-13 14:17:14 | Détail |
| Active drug for chronic migraine treatment. NCT07071506 · New Methods for Evaluating Preventive Migraine Treatment | Migraine | À vérifier | Non applicable | RECRUITING | The study aims to test interactions between drug and placebo-responses in… À vérifier | ClinicalTrials.gov 2026-08-13 14:17:13 | Détail |
| Actual device PFO closure NCT04100135 · RELIEF — GORE® CARDIOFORM Septal Occluder Migraine Clinical Study | Migraine | À vérifier | Non applicable | TERMINATED | Multi-center, prospective, randomized, placebo- and sham-controlled study… À vérifier | ClinicalTrials.gov 2026-08-13 14:17:13 | Détail |
| ACU-BRAIN — Brain Connectome for Acupuncture-treated Migraine Patients NCT04157192 · NCT04157192 | Migraine | Traitement symptomatique | Non applicable | COMPLETED | Acupuncture has been a means of treating headaches and migraine since 2002… À vérifier | ClinicalTrials.gov 2026-08-13 14:17:13 | Détail |
| ACUPMIGRAINE — The Impact of Acupuncture on Biomarkers of Brain Injur… NCT07292506 · NCT07292506 | Migraine | Immunomodulation · Traitement symptomatique | Non applicable | ACTIVE_NOT_RECRUITING | Migraine is more than just a headache-it can involve changes in the brain… À vérifier | ClinicalTrials.gov 2026-08-13 14:17:13 | Détail |
| Amiloride NCT04063540 · APAM — Acid-Sensing Ion Channel and Migraine Disease Proof of Concept Study on t… | Migraine | À vérifier | Phase 2 | RECRUITING | Recent data suggest involvement of Acid-Sensing Ion Channel channels in th… À vérifier | ClinicalTrials.gov 2026-08-13 14:17:13 | Détail |
| App-Based Migraine Treatment: The Health enSuite Study NCT06797076 · NCT06797076 | Migraine | Traitement symptomatique | Non applicable | NOT_YET_RECRUITING | Health enSuite is a suite of applications designed by our research team at… À vérifier | ClinicalTrials.gov 2026-08-13 14:17:13 | Détail |
| Atogepant 60 mg NCT06414044 · STAR — Italian Real-life obServational Study on the effecTiveness, sAfety and To… | Migraine | À vérifier | À vérifier | ACTIVE_NOT_RECRUITING | This goal of this study is to compare three medications used for migraine… À vérifier | ClinicalTrials.gov 2026-08-13 14:17:13 | Détail |
| BE WELL With Migraine: Brain Education and WELLness With Migraine NCT05987592 · NCT05987592 | Migraine | À vérifier | Non applicable | RECRUITING | The goal of this randomized clinical trial is to evaluate two different no… À vérifier | ClinicalTrials.gov 2026-08-13 14:17:13 | Détail |
| Biodegradable occluder NCT06203873 · BioMetal — A Comparison of Biodegradable and Metal Occluders in Patients With PF… | Migraine | Traitement symptomatique | Non applicable | RECRUITING | Migraine is one of the most common chronic neurological disorders, posing… À vérifier | ClinicalTrials.gov 2026-08-13 14:17:13 | Détail |
| Calcitonin-gene related peptide (CGRP) NCT07021859 · Induction of Migraine Attacks With Aura Using Calcitonin Gene-Related Peptide | Migraine | À vérifier | Non applicable | RECRUITING | Calcitonin gene-related peptide (CGRP) is a key neuropeptide in migraine p… À vérifier | ClinicalTrials.gov 2026-08-13 14:17:13 | Détail |
| Clorazepate Dipotassium NCT04726592 · CLORMIG — Efficacy of CLORazepate for the Treatment of MIGraine Attack in the Em… | Migraine | À vérifier | Phase 3 | TERMINATED | The purpose of this study is to evaluate the efficacy of clorazepate in ad… À vérifier | ClinicalTrials.gov 2026-08-13 14:17:13 | Détail |
| Exploring the Effect of the Transcendental Meditation® Technique on M… NCT06695156 · NCT06695156 | Migraine | À vérifier | Non applicable | COMPLETED | This research will explore the effect of the Transcendental Meditation® Te… À vérifier | ClinicalTrials.gov 2026-08-13 14:17:13 | Détail |
| Levcromakalim NCT04853797 · Effect of Ivabradine on Levcromakalim-Induced Symptoms in Individuals With Migra… | Migraine | Traitement symptomatique | Non applicable | COMPLETED | This study aims to explore the effect of Ivabradine on Levcromakalim-induc… À vérifier | ClinicalTrials.gov 2026-08-13 14:17:13 | Détail |
| Mi-Helper NCT06874361 · CALM3 — Cooling to Alleviate Migraine #3 | Migraine | À vérifier | Non applicable | COMPLETED | This is a prospective, double-blind, sham-controlled, randomized, decentra… À vérifier | ClinicalTrials.gov 2026-08-13 14:17:13 | Détail |
| MTX101 NCT06728553 · Safety and Efficacy Trial of MTX101 2mg for the Acute Treatment of Migraine in A… | Migraine | Traitement symptomatique · Thérapie génique | Phase 2 | COMPLETED | The goal of this clinical trial is to learn if drug MTX101 works to treat… À vérifier | ClinicalTrials.gov 2026-08-13 14:17:13 | Détail |
| Nerivio device NCT06023953 · Migraine With and Without Aura Characteristics and Response to Remote Electrical… | Migraine | Traitement symptomatique | À vérifier | COMPLETED | This is a Post-marketing, real-world evidence study investigating the safe… À vérifier | ClinicalTrials.gov 2026-08-13 14:17:13 | Détail |
| Neuromodulation Wearable Device NCT07642414 · A Comprehensive Digital Care Program for Migraine Management | Migraine | À vérifier | Non applicable | RECRUITING | This study evaluates the clinical effectiveness of the Enso for Migraine p… À vérifier | ClinicalTrials.gov 2026-08-13 14:17:13 | Détail |
Découverte scientifique
Recherches et trouvailles 0
Projets précliniques, publications émergentes et programmes de recherche suivis dans le pipeline.
| Molécule / élément | Maladie / population | Objectif | Phase / stade | Statut / preuve | Mécanisme / résumé | Source | Détail |
|---|---|---|---|---|---|---|---|
| Aucune trouvaille ne correspond aux filtres. | |||||||
Bibliographie
Publications 661
Références bibliographiques de la base locale et accès à leur source originale.
| Molécule / élément | Maladie / population | Objectif | Phase / stade | Statut / preuve | Mécanisme / résumé | Source | Détail |
|---|---|---|---|---|---|---|---|
| The impact of timing, dosage, and duration of high-dose methylprednis… Methylprednisolone sodium succinate · PMID 42240612 | Migraine | À vérifier | Publication | PubMed | Voir la publication source The role of high-dose methylprednisolone sodium succinate (MPSS) in acute traumatic spinal cord injury (SCI) remains co… | The journal of spinal cord medicine 2026-08-08 01:00:09 | Source |
| Exploring the Sensitivity Limits of Neuronal Current Imaging With MRI… Visual Stimulation · PMID 42565248 | Migraine | Thérapie génique | Publication | PubMed | Voir la publication source Conventional BOLD-fMRI relies on hemodynamic responses that are temporally and spatially indirect markers of neural act… | Human brain mapping 2026-08-08 01:00:07 | Source |
| Investigating the Time-Course of Verticality Sensitivity Changes Duri… Visual Stimulation · PMID 42562383 | Migraine | À vérifier | Publication | PubMed | Voir la publication source Verticality perception is a multisensory process that relies primarily on visual and vestibular input. Previous studies… | Multisensory research 2026-08-08 01:00:07 | Source |
| Evaluating clinical associations of immediate post-traumatic headache… Prospective ED Headache Cohort Study · PMID 42563150 | Migraine | Thérapie génique | Publication | PubMed | Voir la publication source Post-traumatic headache (PTH) is a frequent early consequence of head traumatic injury, yet emergency departments (EDs)… | The journal of headache and pain 2026-08-08 01:00:06 | Source |
| Retinal layers prognosticate cognitive progression independent of rel… Prospective ED Headache Cohort Study · PMID 42562954 | Migraine | Neuroprotection · Ralentissement de la progression · Thérapie génique | Publication | PubMed | Voir la publication source Optical coherence tomography (OCT) quantifies retinal neuroaxonal loss related to neurodegeneration in people with mult… | Journal of neurology 2026-08-08 01:00:06 | Source |
| Chronic xenogeneic GVHD after CAR T cell therapy limits long-term saf… antibodies against calcitonin-gene related peptide or its receptor · PMID 42566762 | Migraine | Immunomodulation · Thérapie cellulaire | Publication | PubMed | Voir la publication source The clinical successes of chimeric antigen receptor (CAR) T cells represent a major shift in immunotherapy. However, th… | Blood advances 2026-08-08 01:00:05 | Source |
| Comparative analyses of olfactory receptor repertoires in Schizothora… antibodies against calcitonin-gene related peptide or its receptor · PMID 42566844 | Migraine | À vérifier | Publication | PubMed | Voir la publication source The olfactory receptor (OR) genes constitute the molecular basis of fish olfaction, mediating survival behaviors and en… | Comparative biochemistry and physiology. Part D, Genom… 2026-08-08 01:00:05 | Source |
| Digital Remote Assessment of Motor and Speech Changes in Amyotrophic… Click Digital Therapeutic · PMID 42531420 | Migraine | Ralentissement de la progression · Thérapie génique | Publication | PubMed | Voir la publication source Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease with an active trial landscape that relies on the se… | JMIR formative research 2026-08-08 01:00:04 | Source |
| Short dextran-solanesol block copolymer as a bio-based platform for m… Click Digital Therapeutic · PMID 42493094 | Migraine | À vérifier | Publication | PubMed | Voir la publication source Biohybrid block copolymer micelles from natural components hold great promise for biomedical applications; however, int… | Carbohydrate polymers 2026-08-08 01:00:04 | Source |
| Efficacy of MEDI0618, a pH-dependent monoclonal antibody targeting PA… MEDI0618 · PMID 40036725 | Migraine | Immunomodulation · Traitement symptomatique | Publication | PubMed | Voir la publication source Protease activated receptor 2 (PAR2) is a G-protein coupled receptor expressed in meningeal neurons, fibroblasts and ma… | Brain : a journal of neurology 2026-08-08 01:00:03 | Source |
| The development of proteinase-activated receptor-2 modulators and the… MEDI0618 · PMID 33242065 | Migraine | Immunomodulation | Publication | PubMed | Voir la publication source Protease-activated receptor-2 (PAR2) has been extensively studied since its discovery in the mid-1990. Despite the adva… | Biochemical Society transactions 2026-08-08 01:00:03 | Source |
| Delivery Model Matters for Digital Interventions in Pain Self-Managem… Care as usual · PMID 42475133 | Migraine | Traitement symptomatique | Publication | PubMed | Voir la publication source Digital health interventions can improve access to and outreach of evidence-based support for people living with chroni… | Journal of medical Internet research 2026-08-08 01:00:02 | Source |
| Process Evaluation of a Problem-Solving Intervention with Workplace I… Care as usual · PMID 42541653 | Migraine | À vérifier | Publication | PubMed | Voir la publication source This process evaluation examined the implementation of a problem-solving intervention with workplace involvement (PSI-W… | Journal of occupational rehabilitation 2026-08-08 01:00:02 | Source |
| Ultrasound-Guided Stellate Ganglion Block in Fibromyalgia: A Randomiz… Ultrasound guided Stellate ganglion block · PMID 42530408 | Migraine | Traitement symptomatique | Publication | PubMed | Voir la publication source Fibromyalgia is a chronic pain syndrome characterized by widespread pain, fatigue, and sleep disturbance. Many patients… | Pain research & management 2026-08-08 01:00:00 | Source |
| Post-dural Puncture Headache During Bacteraemia: Successful Managemen… ultrasound guided Greater occipital nerve block · PMID 42535063 | Migraine | Traitement symptomatique | Publication | PubMed | Voir la publication source Epidural blood patch (EBP) is considered the most effective interventional treatment for post-dural puncture headache (… | Cureus 2026-08-08 00:59:59 | Source |
| Ultrasound-Guided Greater Occipital Nerve Block Across Headache Pheno… ultrasound guided Greater occipital nerve block · PMID 42533183 | Migraine | Traitement symptomatique | Publication | PubMed | Voir la publication source Greater occipital nerve blocks (GONBs) are used across headache phenotypes, but short-term effectiveness and predictors… | Pain and therapy 2026-08-08 00:59:59 | Source |
| CGRP-pathway exposure during the pre-EBP interval in spontaneous intr… Galcanezumab · PMID 42432562 | Migraine | Traitement symptomatique | Publication | PubMed | Voir la publication source Given hypothesized involvement of calcitonin gene-related peptide (CGRP) in trigeminovascular pain and the frequent mig… | BMC neurology 2026-08-08 00:59:58 | Source |
| Comparing synthetic and biological therapy for the treatment of clust… Galcanezumab · PMID 42493477 | Migraine | Traitement symptomatique | Publication | PubMed | Voir la publication source Cluster headache is an extremely painful and severely disabling primary headache disorder that, despite its profound im… | Expert review of neurotherapeutics 2026-08-08 00:59:58 | Source |
| Compound Chamomile and Lidocaine Hydrochloride Gel in Oral Diseases:… Lidocaine Hydrochloride · PMID 42558651 | Migraine | Immunomodulation · Traitement symptomatique · Thérapie génique | Publication | PubMed | Voir la publication source Oral diseases frequently entail microbial infections or mucosal damage, typically accompanied by pain and discomfort. P… | Drug design, development and therapy 2026-08-08 00:59:57 | Source |
| Impact of Menthol Concentration on Ketoprofen Permeation and Photosta… Lidocaine Hydrochloride · PMID 42518428 | Migraine | Immunomodulation · Traitement symptomatique | Publication | PubMed | Voir la publication source Topical nonsteroidal anti-inflammatory drugs provide localized pain relief while reducing the risk of systemic adverse… | ACS omega 2026-08-08 00:59:57 | Source |
Exploration — prudence
Pistes exploratoires 5
Rapprochements mécanistiques et hypothèses de recherche : ils ne constituent pas une preuve d’efficacité ni une recommandation thérapeutique.
Hypothèses non validéesÀ confirmer par des travaux précliniques, cliniques et une revue scientifique indépendante.
| Molécule / élément | Maladie / population | Objectif | Phase / stade | Statut / preuve | Mécanisme / résumé | Source | Détail |
|---|---|---|---|---|---|---|---|
| Bavisant BRAVEinMS — Bavisant | Migraine | Remyélinisation · Neuroprotection · Immunomodulation | Hypothèse exploratoire | Rapprochement automatique non validé | Antagonisme du récepteur H3 de l’histamine Bavisant est étudié dans Sclérose en plaques et documente plusieurs axes biologiques pouvant être pertinents pour Migra… | Rapprochement Biomedical Watch · Sclérose en plaques | Détail |
| Tol-MP Tol-MP — tolérance immunitaire spécifique de la myéline | Migraine | Neuroprotection · Immunomodulation | Hypothèse exploratoire | Rapprochement automatique non validé | Microparticules biodégradables chargées en rapamycine et fonctionnalisées… Tol-MP est étudié dans Sclérose en plaques et documente plusieurs axes biologiques pouvant être pertinents pour Migrain… | Rapprochement Biomedical Watch · Sclérose en plaques | Détail |
| SetPoint System SetPoint System — SetPoint Medical | Migraine | Immunomodulation | Hypothèse exploratoire | Rapprochement automatique non validé | re ApplicationsPublicationsCompanyCareersNewsGet startedGet startedNewsThe… SetPoint System est étudié dans Sclérose en plaques et documente plusieurs axes biologiques pouvant être pertinents pou… | Rapprochement Biomedical Watch · Sclérose en plaques | Détail |
| 4-octyl itaconate et dérivés Dérivés de l’itaconate — neuroinflammation | Migraine | Neuroprotection · Immunomodulation | Hypothèse exploratoire | Rapprochement automatique non validé | Modulation immunométabolique de la microglie 4-octyl itaconate et dérivés est étudié dans Sclérose latérale amyotrophique et documente plusieurs axes biologiques po… | Rapprochement Biomedical Watch · Sclérose latérale amy… | Détail |
| N-PPG N-PPG — modulation métabolique cérébrale | Migraine | Remyélinisation indirecte / réparation · Neuroprotection | Hypothèse exploratoire | Rapprochement automatique non validé | Modulation métabolique et mitohormèse N-PPG est étudié dans Maladie de Huntington et documente plusieurs axes biologiques pouvant être pertinents pour Migrai… | Rapprochement Biomedical Watch · Maladie de Huntington | Détail |